The Pittsburgh Penguins Hockey Research and Development department is now accepting applications for their new fellowship and internship program, it was announced today. These programs mark the first ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced updates on ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

The MarketWatch News Department was not involved in the creation of this content. Recognized for Advancing (Z)-Endoxifen, a Precision-Engineered Endocrine Therapy with Potential Across Multiple Breast ...

The Mississippi Institutions of Higher Learning approved the center and degree programs during the first Board of Trustees ...

America’s greatest national security threat is an enemy born from and nurtured by the Pentagon: crippling bureaucracy. It starves the oxygen from good ideas, good people, and good technologies while ...

WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine presents an ambitious and comprehensive long-term vision for the field of particle physics to further our ...

Even as the U.S. Department of Education dismantles large swaths of the Institute of Education Sciences, a bipartisan group of lawmakers wants to create a new research center modeled on the Pentagon’s ...

SEATTLE, Dec. 17, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other ...